Drug Search Results
More Filters [+]

Isoxsuprine

Alternative Names: isoxsuprine
Latest Update: 2024-02-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRA Antagonist,ADRB Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Brazil | Chile | Egypt | India | Indonesia | Ireland | Italy | New Zealand | Peru | Philippines | Portugal | Taiwan | Ukraine | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: University of New Mexico
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Isoxsuprine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Multiple Sclerosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT03752307

P2

Completed

Multiple Sclerosis

2023-07-06

Recent News Events